adda

ADDA is a non-proteinogenic amino acid existed in toxins produced by cyanobacteria.

ADDA 5 hydrochloride is a specific and non-competitive inhibitor of CcO (cytochrome c oxidase) that inhibits the proliferation of chemically sensitive and chemically resistant glioma cells and blocks cell proliferation and neurosphere formation in glioma stem cell cultures.

YYRADDA, a polypeptide, enhances collagen production within the skin's extracellular matrix, thus improving skin appearance and aiding the repair of damaged skin [1].

Squalene (AddaVax) is an intermediate in cholesterol synthesis. Squalene has a variety of pharmacological properties, such as antilipemic, hepatoprotective, anti-atherosclerotic, cardioprotective, antioxidant, antitumor and antifungal.

(E/Z)-Squalene ((E/Z)-AddaVax) regulates intracellular reactive oxidant species (ROS) production, induces apoptosis and necrosis in a concentration- and time-dependent manner, accumulates in the liver, and lowers hepatic cholesterol and triglycerides.

DREADD agonist 21 is a potent agonist of human muscarinic acetylcholine M3 receptors (EC50=1.7 nM).

DREADD agonist 21 dihydrochloride is a potent agonist of human muscarinic acetylcholine M3 receptors (hM3Dq) with an EC50 of 1.7 nM [1].

7-TFA-ap-7-Deaza-ddA (compound 19c, US20060281100A1), a nucleotide derivative, is appropriate for synthesizing thiotriphosphate nucleotide dye terminators used in DNA sequencing reactions.

ML328 is a potent and selective inhibitor of bacterial AddAB(IC50 = 1.0 μM) and RecBCD(IC50 = 4.8 μM) helicase-nucleases.

Ad-Daidzein (Standard) is a reference standard of Ad-Daidzein intended for quantitative analysis, quality control, and related biochemical research applications.

Body Protection Compound 157 (BPC 157) is a pentadecapeptide derived from BPC, identified in gastric juice, exhibiting diverse biological activities. At 2 µg/ml, BPC 157 enhances primary rat tendon fibroblast cell migration and F-actin formation. Furthermore, doses of 0.01 and 10 µg/kg, intraperitoneally (i.p.), mitigate paw swelling, bone erosion, and mononuclear cell infiltration in the joints of rats with rheumatoid arthritis induced by complete Freund's adjuvant (CFA). It also diminishes gastric ulcer size in rats caused by indomethacin, aspirin, or diclofenac at these doses. Additionally, BPC 157 reduces catalepsy duration and tremor severity in a mouse model of Parkinson's disease triggered by MPTP.